See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $950B | 15.5x | 35.2x | |
| $499B | 5.4x | 14.2x | |
| $474B | 7.8x | 18.5x | |
| $311B | 4.1x | 10.3x | |
| $301B | 5.2x | 14.9x | |
| $274B | 5.0x | 12.1x | |
| $254B | 3.9x | 8.7x | |
| $226B | 6.3x | 12.4x | |
| $224B | 4.7x | 9.7x | |
| $188B | 3.0x | 7.6x | |
| $173B | 5.9x | 11.2x | |
| $134B | 2.6x | 8.6x | |
| $130B | 2.7x | 7.6x | |
| $113B | 2.7x | 7.9x | |
| $106B | 8.9x | 21.8x | |
| $85.4B | 10.7x | 21.0x | |
| $70.4B | 2.4x | 8.9x | |
| $70.0B | 1.3x | 6.3x | |
| $69.7B | 2.8x | 10.0x | |
| $66.1B | 4.2x | 12.5x | |
| $57.5B | 6.1x | 14.0x | |
| $52.2B | 11.4x | 38.0x | |
| $52.0B | 11.3x | 37.8x | |
| $51.5B | 5.6x | 19.0x | |
| $45.0B | 7.2x | 25.1x | |
| $43.6B | 2.6x | 8.7x | |
| $39.4B | 3.0x | 14.5x | |
| $33.6B | 3.1x | 14.2x | |
| $30.6B | 10.9x | 31.7x | |
| $27.0B | 1.7x | 7.2x | |
| $26.8B | 2.7x | 8.7x | |
| $26.3B | 13.0x | 34.9x | |
| $25.9B | 1.8x | 6.2x | |
| $25.0B | 1.9x | 9.0x | |
| $23.9B | 8.0x | 8.4x | |
| $22.0B | 2.2x | 6.3x | |
| $20.9B | 57.4x | 1714.8x | |
| $19.9B | 136.4x | 259.1x | |
| $19.1B | 10.6x | 81.3x | |
| $17.0B | 2.0x | 8.0x | |
| $15.4B | 4.2x | 11.3x | |
| $15.3B | 3.3x | 12.4x | |
| $14.8B | 4.9x | 13.2x | |
| $14.8B | 10.5x | 32.0x | |
| $13.6B | 4.9x | 20.5x | |
| $13.6B | 4.6x | 12.0x | |
| $13.4B | 29.8x | -901.0x | |
| $13.2B | 2.3x | 13.0x | |
| $12.9B | 4.0x | 16.4x | |
| $12.4B | 45.3x | -270.6x | |
| $12.3B | 2.1x | 14.4x | |
| $11.9B | 2.8x | 7.4x | |
| $11.9B | 0.3x | 5.3x | |
| $11.6B | 3.0x | 12.2x | |
| $11.2B | 3.6x | 9.0x | |
| $11.0B | 7.1x | 28.3x | |
| $10.8B | 3.9x | 13.8x | |
| $10.6B | 13.1x | 41.4x | |
| $10.6B | 3.2x | 7.8x | |
| $10.5B | 3.8x | 14.9x | |
| $10.3B | n/a | n/a | |
| $10.3B | 2.5x | 9.3x | |
| $10.1B | 1.6x | 5.2x | |
| $10.1B | 1.6x | 12.9x | |
| $9.9B | 4.6x | 12.6x | |
| $9.4B | 3.9x | 6.1x | |
| $9.0B | 6.9x | 10.7x | |
| $8.5B | 833.1x | -40.2x | |
| $8.2B | 1.6x | 12.6x | |
| $8.0B | n/a | n/a | |
| $8.0B | 2.2x | 10.5x | |
| $7.9B | n/a | n/a | |
| $7.5B | 4.0x | 19.3x | |
| $7.4B | 4.7x | 23.7x | |
| $7.0B | 2.2x | 9.9x | |
| $6.9B | 9.0x | 33.2x | |
| $6.8B | 17.9x | -478.8x | |
| $6.5B | 5.6x | 19.1x | |
| $6.5B | 1.5x | 8.5x | |
| $6.4B | 2.8x | 10.1x | |
| $6.3B | 4.2x | 49.6x | |
| $6.2B | 16.7x | 24.9x | |
| $6.1B | 2.1x | 9.1x | |
| $5.9B | 1.8x | 7.0x | |
| $5.8B | 106.1x | 13930.0x | |
| $5.8B | 1.8x | 7.8x | |
| $5.7B | 3.5x | 18.6x | |
| $5.5B | 2.9x | 11.3x | |
| $5.2B | n/a | n/a | |
| $5.1B | 8.8x | 26.2x | |
| $5.0B | 5.9x | 27.2x | |
| $5.0B | n/a | n/a | |
| $4.9B | 1.8x | 4.9x | |
| $4.9B | 14.2x | -70.4x | |
| $4.9B | n/a | -18.7x | |
| $4.9B | 10.4x | 32.3x | |
| $4.9B | 5.2x | 13.6x | |
| $4.5B | 5.4x | 19.0x | |
| $4.5B | 10.5x | 32.2x | |
| $4.4B | 3386.3x | -15.4x | |
| $4.4B | 3.1x | 11.3x | |
| $4.3B | 4.1x | 19.0x | |
| $4.3B | 8.5x | 22.4x | |
| $4.1B | 1.6x | 8.9x | |
| $3.9B | n/a | n/a | |
| $3.8B | 2.6x | 9.8x | |
| $3.8B | n/a | -23.8x | |
| $3.7B | 5.5x | 15.2x | |
| $3.7B | 7.4x | 16.3x | |
| $3.6B | 124.5x | n/a | |
| $3.6B | 2.2x | 10.7x | |
| $3.6B | 32.2x | -370.5x | |
| $3.6B | 5.3x | 17.8x | |
| $3.5B | 4.2x | 15.7x | |
| $3.5B | 11.2x | 69.8x | |
| $3.4B | 24776.0x | -9.0x | |
| $3.2B | 4.7x | n/a | |
| $3.2B | 6.8x | -182.6x | |
| $3.1B | 36.7x | -28.1x | |
| $3.1B | 9.3x | -186.8x | |
| $3.1B | 1.5x | 10.0x | |
| $3.0B | 2.2x | 8.2x | |
| $3.0B | 2.4x | 11.5x | |
| $2.9B | 13.4x | -104.7x | |
| $2.9B | n/a | -15.2x | |
| $2.8B | 6.8x | -40.4x | |
| $2.8B | n/a | -12.5x | |
| $2.7B | 4.1x | 14.1x | |
| $2.7B | 4.7x | 18.4x | |
| $2.7B | 4.2x | 30.5x | |
| $2.7B | 6.8x | 20.3x | |
| $2.7B | n/a | n/a | |
| $2.7B | 4.2x | 10.3x | |
| $2.6B | 21.7x | -122.8x | |
| $2.6B | 15.4x | 23.4x | |
| $2.4B | 12.5x | 37.2x | |
| $2.4B | 2.9x | 14.2x | |
| $2.3B | 3.4x | 17.7x | |
| $2.3B | 3.0x | 19.0x | |
| $2.3B | 6.2x | 17.8x | |
| $2.3B | 3.7x | 14.6x | |
| $2.2B | 2.7x | 10.3x | |
| $2.2B | 14.9x | n/a | |
| $2.2B | 8.2x | 78.2x | |
| $2.2B | 6.9x | 17.8x | |
| $2.1B | 5.5x | 15.2x | |
| $2.0B | n/a | -18.1x | |
| $2.0B | 8.9x | -68.7x | |
| $2.0B | 2.6x | 4.4x | |
| $1.9B | n/a | n/a | |
| $1.8B | 6.4x | n/a | |
| $1.8B | 7.3x | -4.7x | |
| $1.7B | 4.0x | n/a | |
| $1.7B | 11.8x | 29.2x | |
| $1.7B | 0.8x | 4.5x | |
| $1.7B | 4.0x | 14.8x | |
| $1.7B | 8.8x | 28.5x | |
| $1.7B | n/a | -7.9x | |
| $1.7B | 6.3x | 24.8x | |
| $1.6B | 2.5x | 11.3x | |
| $1.6B | 52.1x | -8.3x | |
| $1.6B | 15.0x | 331.1x | |
| $1.6B | 2.2x | 5.9x | |
| $1.6B | n/a | n/a | |
| $1.6B | 13.6x | -21.4x | |
| $1.6B | n/a | n/a | |
| $1.5B | n/a | -17.8x | |
| $1.5B | n/a | n/a | |
| $1.4B | 15.2x | n/a | |
| $1.4B | 5.0x | 9.8x | |
| $1.4B | 3.6x | -297.5x | |
| $1.4B | 6.0x | 25.3x | |
| $1.4B | 499.2x | n/a | |
| $1.4B | 5.0x | 29.3x | |
| $1.4B | 3.5x | n/a | |
| $1.4B | n/a | n/a | |
| $1.4B | 24.0x | 53.1x | |
| $1.3B | 2.2x | -73.3x | |
| $1.3B | 41.0x | -12.2x | |
| $1.3B | 0.6x | 6.4x | |
| $1.3B | 7.6x | -1491.3x | |
| $1.2B | 63.3x | -10.7x | |
| $1.2B | 2.6x | 14.7x | |
| $1.2B | n/a | -6.8x | |
| $1.2B | 1.2x | 5.0x | |
| $1.2B | 3.1x | 13.3x | |
| $1.2B | 22.9x | n/a | |
| $1.2B | 10.2x | 35.3x | |
| $1.1B | 8.3x | 27.1x | |
| $1.1B | 3.2x | 34.6x | |
| $1.1B | 10.0x | -9.7x | |
| $1.1B | 6.9x | -7.2x | |
| $1.0B | n/a | n/a | |
| $1.0B | 391.7x | -7.0x | |
| $1.0B | 20.4x | -9.2x | |
| $995M | n/a | n/a | |
| $992M | 6.5x | -3.6x | |
| $987M | 2.6x | 3.0x | |
| $969M | 3.2x | 7.1x | |
| $963M | 1.6x | -7.2x | |
| $961M | n/a | n/a | |
| $956M | 15.8x | n/a | |
| $949M | n/a | -6.1x | |
| $949M | 1.1x | 4.8x | |
| $945M | 2.9x | 34.1x | |
| $924M | 872.0x | -9.4x | |
| $903M | n/a | -6.2x | |
| $896M | n/a | -4.6x | |
| $895M | 7.6x | 27.5x | |
| $885M | 2.3x | 48.6x | |
| $814M | 129118.9x | -7.2x | |
| $794M | 1.3x | 6.5x | |
| $788M | n/a | n/a | |
| $778M | 17.3x | 140.9x | |
| $777M | 59.4x | n/a | |
| $760M | n/a | n/a | |
| $736M | 1.7x | 8.1x | |
| $731M | n/a | n/a | |
| $723M | n/a | -7.0x | |
| $715M | n/a | n/a | |
| $714M | 5.6x | -4.4x | |
| $696M | n/a | -6.1x | |
| $672M | 2.5x | 11.3x | |
| $661M | n/a | n/a | |
| $659M | 6.3x | 23.1x | |
| $603M | 39.5x | -7.9x | |
| $602M | n/a | n/a | |
| $590M | 78.0x | -3.8x | |
| $588M | 3.4x | 17.6x | |
| $584M | 45.2x | -1.8x | |
| $577M | n/a | -3.9x | |
| $571M | n/a | -4.5x | |
| $559M | 41.3x | 80.6x | |
| $553M | n/a | n/a | |
| $553M | n/a | -3.7x | |
| $549M | 27.9x | -173.6x | |
| $536M | n/a | -3.8x | |
| $526M | 184.0x | -26.8x | |
| $518M | 17.0x | -6.4x | |
| $509M | 5.2x | 14.5x | |
| $505M | 20398.2x | n/a | |
| $477M | n/a | n/a | |
| $470M | 46.5x | -3.7x | |
| $467M | 10.3x | -6.0x | |
| $458M | 3.1x | -3.5x | |
| $434M | 2.3x | 9.9x | |
| $425M | 1.4x | 9.7x | |
| $408M | n/a | n/a | |
| $407M | 77.0x | -12.5x | |
| $404M | 6.2x | -21.2x | |
| $400M | 1.1x | 7.9x | |
| $396M | 6.3x | 24.9x | |
| $393M | 28.6x | -8.9x | |
| $391M | 1.2x | 4.4x | |
| $385M | 2.1x | -3.2x | |
| $372M | 3.0x | 49.8x | |
| $353M | n/a | n/a | |
| $349M | 17.9x | -1203.7x | |
| $347M | 14.7x | -7.0x | |
| $343M | 11.6x | -1.7x | |
| $335M | n/a | n/a | |
| $332M | 1.8x | 7.8x | |
| $328M | 1.4x | n/a | |
| $327M | n/a | n/a | |
| $319M | 0.8x | 9.5x | |
| $318M | 4.6x | 24.9x | |
| $312M | n/a | n/a | |
| $262M | n/a | n/a | |
| $259M | n/a | -1.6x | |
| $256M | 31.2x | -8.4x | |
| $250M | 2.4x | 7.4x | |
| $246M | n/a | n/a | |
| $243M | 25498.3x | -2.7x | |
| $242M | 11.0x | -1.0x | |
| $236M | 5.9x | -27.4x | |
| $233M | 12.8x | 1471.4x | |
| $230M | n/a | -1.1x | |
| $230M | 8.8x | n/a | |
| $229M | n/a | -30.6x | |
| $226M | n/a | n/a | |
| $221M | 5.0x | 36.9x | |
| $220M | n/a | n/a | |
| $219M | n/a | -2.0x | |
| $217M | 3.4x | 7.5x | |
| $209M | 4.6x | 21.0x | |
| $206M | 2.5x | -9.1x | |
| $206M | 6.9x | n/a | |
| $205M | n/a | n/a | |
| $199M | 1.7x | 17.5x | |
| $194M | n/a | n/a | |
| $192M | n/a | n/a | |
| $192M | 2.9x | n/a | |
| $192M | 6.7x | n/a | |
| $184M | 50.6x | -4.2x | |
| $180M | 8.9x | -4.2x | |
| $175M | 32.4x | -0.8x | |
| $167M | 30.1x | -12.7x | |
| $162M | n/a | -11.6x | |
| $158M | 106.4x | -4.2x | |
| $148M | 33.7x | -2.2x | |
| $145M | 10.7x | -3.5x | |
| $143M | 2.6x | 113.8x | |
| $142M | 17.5x | -6.2x | |
| $137M | 6.0x | -3.7x | |
| $137M | n/a | n/a | |
| $136M | n/a | n/a | |
| $132M | 24.9x | -10.5x | |
| $131M | 7.6x | -2.6x | |
| $131M | 2.2x | n/a | |
| $126M | n/a | n/a | |
| $125M | n/a | n/a | |
| $123M | 39.9x | -2.2x | |
| $119M | n/a | n/a | |
| $117M | n/a | n/a | |
| $111M | n/a | -8.2x | |
| $109M | 88.5x | -21.9x | |
| $109M | 1.6x | 9.7x | |
| $108M | n/a | n/a | |
| $107M | 3.4x | -1.6x | |
| $102M | n/a | n/a | |
| $102M | 1.2x | -3.4x | |
| $100M | 6.7x | 23.1x | |
| $99.5M | n/a | -2.0x | |
| $93.8M | 860.4x | n/a | |
| $92.3M | 19.4x | -0.7x | |
| $88.7M | n/a | n/a | |
| $87.5M | 7.9x | -112.6x | |
| $84.3M | n/a | n/a | |
| $84.2M | n/a | n/a | |
| $83.9M | n/a | n/a | |
| $82.8M | 20.0x | -6.1x | |
| $76.9M | 3.1x | 12.4x | |
| $76.6M | n/a | n/a | |
| $74.0M | n/a | n/a | |
| $70.5M | 9.2x | -2.5x | |
| $69.8M | 705.9x | n/a | |
| $67.6M | 61.9x | -7.2x | |
| $63.5M | n/a | n/a | |
| $62.5M | n/a | n/a | |
| $60.0M | 0.3x | -1.2x | |
| $56.7M | 6.6x | -7.7x | |
| $55.1M | n/a | n/a | |
| $55.1M | 0.8x | -0.2x | |
| $54.2M | n/a | n/a | |
| $53.1M | 5.6x | 2.7x | |
| $52.8M | n/a | n/a | |
| $52.2M | 0.5x | -0.8x | |
| $48.5M | 24.9x | -166.3x | |
| $45.1M | 9.4x | n/a | |
| $44.0M | 67.5x | -4.5x | |
| $43.9M | n/a | n/a | |
| $43.7M | n/a | -2.4x | |
| $40.0M | 5.7x | n/a | |
| $39.6M | 10.4x | n/a | |
| $38.9M | n/a | n/a | |
| $37.6M | 1.5x | 10.5x | |
| $33.3M | n/a | n/a | |
| $33.1M | 8.5x | n/a | |
| $31.9M | 1.7x | 39.8x | |
| $31.6M | 33.8x | n/a | |
| $30.6M | 9.9x | -7.2x | |
| $30.4M | n/a | n/a | |
| $29.3M | n/a | n/a | |
| $29.3M | n/a | n/a | |
| $29.0M | 22.7x | -0.4x | |
| $28.7M | n/a | n/a | |
| $27.9M | n/a | n/a | |
| $27.8M | n/a | n/a | |
| $27.6M | 52.5x | -2.3x | |
| $27.1M | n/a | -5.9x | |
| $26.4M | n/a | n/a | |
| $25.9M | n/a | n/a | |
| $25.2M | 12.4x | 156.5x | |
| $24.2M | 3.4x | -1.2x | |
| $24.0M | n/a | n/a | |
| $23.9M | n/a | -13.4x | |
| $23.1M | n/a | n/a | |
| $22.9M | n/a | -5.5x | |
| $22.7M | n/a | n/a | |
| $21.8M | n/a | n/a | |
| $20.8M | n/a | n/a | |
| $19.8M | n/a | n/a | |
| $19.8M | n/a | n/a | |
| $19.5M | 19.0x | -5.2x | |
| $19.4M | 2.8x | 8.1x | |
| $19.3M | n/a | n/a | |
| $19.3M | 3.1x | -0.2x | |
| $19.1M | n/a | n/a | |
| $18.3M | 17.4x | -7.6x | |
| $16.5M | 7.4x | -2.1x | |
| $16.0M | n/a | n/a | |
| $15.0M | 2.8x | -5.4x | |
| $14.9M | n/a | n/a | |
| $14.9M | n/a | -3.7x | |
| $14.6M | n/a | n/a | |
| $14.4M | n/a | -3.4x | |
| $14.3M | n/a | n/a | |
| $14.1M | n/a | n/a | |
| $14.0M | n/a | n/a | |
| $13.9M | n/a | n/a | |
| $13.6M | n/a | n/a | |
| $13.4M | n/a | n/a | |
| $13.1M | 14.1x | -19.9x | |
| $13.1M | n/a | n/a | |
| $12.8M | n/a | n/a | |
| $12.3M | 2.1x | -1.3x | |
| $12.0M | 0.7x | -9.9x | |
| $12.0M | n/a | n/a | |
| $11.8M | n/a | n/a | |
| $11.4M | 3.6x | -4.2x | |
| $11.4M | 8.4x | -27.1x | |
| $11.1M | 66.8x | -5.0x | |
| $10.7M | n/a | n/a | |
| $10.5M | n/a | n/a | |
| $9.6M | n/a | n/a | |
| $9.4M | n/a | n/a | |
| $9.3M | n/a | -4.7x | |
| $8.1M | n/a | -1.5x | |
| $8.0M | n/a | -8.8x | |
| $7.9M | n/a | n/a | |
| $7.8M | n/a | n/a | |
| $7.5M | n/a | n/a | |
| $7.5M | n/a | n/a | |
| $7.2M | n/a | n/a | |
| $7.2M | n/a | n/a | |
| $7.2M | n/a | -1.9x | |
| $6.6M | 8.4x | -0.5x | |
| $6.3M | 5.4x | -0.2x | |
| $6.0M | 6.5x | -0.5x | |
| $5.2M | 4.1x | 2.4x | |
| $5.1M | 10.2x | n/a | |
| $4.9M | 0.7x | -3.1x | |
| $4.9M | 2.7x | -0.4x | |
| $4.6M | n/a | -1.4x | |
| $4.6M | 39.2x | -1.5x | |
| $4.1M | n/a | -2.5x | |
| $4.0M | n/a | n/a | |
| $3.8M | 27.8x | -1.2x | |
| $3.7M | n/a | n/a | |
| $3.4M | n/a | n/a | |
| $3.2M | n/a | n/a | |
| $3.1M | n/a | n/a | |
| $3.0M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| $1.7M | 2.1x | n/a | |
| $1.7M | n/a | n/a | |
| $1.7M | n/a | n/a | |
| $1.4M | n/a | 0.3x | |
| $1.3M | n/a | n/a | |
| $1.3M | n/a | n/a | |
| $0.7M | n/a | n/a | |
| $0.5M | n/a | n/a | |
| $0.4M | n/a | n/a | |
| $0.1M | n/a | n/a | |
| $0.1M | n/a | n/a | |
| -$0.1M | -0.2x | 0.0x | |
| -$0.2M | n/a | n/a | |
| -$0.3M | n/a | n/a | |
| -$0.3M | n/a | n/a | |
| -$0.4M | n/a | n/a | |
| -$1.3M | -0.2x | 0.1x | |
| -$6.0M | n/a | n/a | |
| -$7.5M | n/a | 0.9x | |
| -$8.3M | n/a | n/a | |
| -$31.3M | -17.7x | n/a | |
| -$80.5M | n/a | 0.5x | |
| -$117M | -4.4x | 0.8x | |
| -$1.4B | -4.6x | 6.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals